Correlation Between Rezolute and Vincerx Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Rezolute and Vincerx Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Rezolute and Vincerx Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Rezolute and Vincerx Pharma, you can compare the effects of market volatilities on Rezolute and Vincerx Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Rezolute with a short position of Vincerx Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Rezolute and Vincerx Pharma.

Diversification Opportunities for Rezolute and Vincerx Pharma

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Rezolute and Vincerx is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Rezolute and Vincerx Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vincerx Pharma and Rezolute is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Rezolute are associated (or correlated) with Vincerx Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vincerx Pharma has no effect on the direction of Rezolute i.e., Rezolute and Vincerx Pharma go up and down completely randomly.

Pair Corralation between Rezolute and Vincerx Pharma

Given the investment horizon of 90 days Rezolute is expected to generate 0.82 times more return on investment than Vincerx Pharma. However, Rezolute is 1.21 times less risky than Vincerx Pharma. It trades about -0.2 of its potential returns per unit of risk. Vincerx Pharma is currently generating about -0.36 per unit of risk. If you would invest  563.00  in Rezolute on August 29, 2024 and sell it today you would lose (84.00) from holding Rezolute or give up 14.92% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Rezolute  vs.  Vincerx Pharma

 Performance 
       Timeline  
Rezolute 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Rezolute are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable essential indicators, Rezolute is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Vincerx Pharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in December 2024. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Rezolute and Vincerx Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Rezolute and Vincerx Pharma

The main advantage of trading using opposite Rezolute and Vincerx Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Rezolute position performs unexpectedly, Vincerx Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will offset losses from the drop in Vincerx Pharma's long position.
The idea behind Rezolute and Vincerx Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Complementary Tools

Volatility Analysis
Get historical volatility and risk analysis based on latest market data
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets